Rare Disease Challenges At US FDA: CDER Director Says More Staff, Not Reorganization, Will Fix Issues

 
• By Derrick Gingery
company reorganization
Advocates continue pushing for a Rare Disease Center of Excellence at the FDA, despite agency opposition. • Source: Alamy

More from Rare Diseases

More from Pink Sheet